Analysts expect Vanda Pharmaceuticals Inc. to report revenue of 66.75 M for Q4 26, against a range of 62.41 M to 71.08 M. The most recent reported quarter, Q3 26, came in at 69.81 M, a 4.3% beat against the 66.92 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 53.19 M | 50.04 M | 52.59 M | 56.26 M | 57.22 M | 51.72 M | 50.53 M | 69.81 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 53.11 M | 51.99 M | 60.94 M | 62.14 M | 59.19 M | 57.52 M | 62.04 M | 72.39 M | 71.08 M | 75.40 M | 84.36 M | 84.69 M | 92.20 M | 88.13 M | 93.07 M | 95.73 M | |||||||||
| Low Estimate | 46.42 M | 43.61 M | 51.74 M | 52.97 M | 55.51 M | 48.64 M | 53.26 M | 61.45 M | 62.41 M | 65.96 M | 78.82 M | 71.77 M | 76.00 M | 77.04 M | 87.35 M | 85.82 M | |||||||||
| Consensus Estimate | 49.77 M | 47.80 M | 56.34 M | 57.56 M | 57.35 M | 53.08 M | 57.65 M | 66.92 M | 66.75 M | 70.68 M | 81.59 M | 78.23 M | 84.10 M | 82.58 M | 90.21 M | 90.78 M |
Analysts expect Vanda Pharmaceuticals Inc. to report earnings per share of -0.31 for Q4 26, against a range of -0.32 to -0.30. The most recent reported quarter, Q3 26, came in at -0.37, a 47.9% beat against the -0.71 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.08 | -0.50 | -0.46 | -0.38 | -2.39 | -0.82 | -1.04 | -0.37 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.11 | -0.53 | -0.32 | -0.39 | -0.86 | -0.64 | -0.53 | -0.65 | -0.30 | -0.23 | -0.16 | -0.06 | -0.42 | -0.06 | -0.05 | 0.16 | |||||||||
| Low Estimate | -0.11 | -0.59 | -0.38 | -0.43 | -0.98 | -0.70 | -0.57 | -0.77 | -0.32 | -0.25 | -0.18 | -0.06 | -0.50 | -0.06 | -0.05 | 0.14 | |||||||||
| Consensus Estimate | -0.11 | -0.56 | -0.35 | -0.41 | -0.92 | -0.67 | -0.55 | -0.71 | -0.31 | -0.24 | -0.17 | -0.06 | -0.46 | -0.06 | -0.05 | 0.15 |
Pull Wall Street consensus for Vanda Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VNDA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VNDA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VNDA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();